Amylmetacresol
As of the edition of 20 October 2026, Amylmetacresol is a small molecule: marketed, first approved in 1984 (ES).
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Marketed; latest approval 2012
- Kind
- Small molecule
- Brand name
- STREPSILS pastillas para chupar sabor menta
- First approved
- 1 July 1984 (ES)
- Approvals on record
- 10 in 4 regions
- Holder of the most recent approval
- Reckitt Benckiser; 2 holders in all
US protection
No US approval on record.
With no US approval on record there are no listed US patents or exclusivities.
This is the US only.
Who has held its approvals
| Company | Role | Years |
|---|---|---|
| Reckitt Benckiser | Applicant | 2009 to now |